Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis (Q37080228)

18 August 2017

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis (English)

1 reference

18 August 2017

0 references

0 references

0 references

16

1 reference

18 August 2017

M O Harris-Love

1

1 reference

18 August 2017

J A Shrader

2

1 reference

18 August 2017

D Koziol

3

1 reference

18 August 2017

N Pahlajani

4

1 reference

18 August 2017

M Jain

5

1 reference

18 August 2017

M Smith

6

1 reference

18 August 2017

H L Cintas

7

1 reference

18 August 2017

C L McGarvey

8

1 reference

18 August 2017

L James-Newton

9

1 reference

18 August 2017

A Pokrovnichka

10

1 reference

18 August 2017

B Moini

11

1 reference

18 August 2017

I Cabalar

12

1 reference

18 August 2017

D J Lovell

13

1 reference

18 August 2017

R Wesley

14

1 reference

18 August 2017

P H Plotz

15

1 reference

18 August 2017

J E Hicks

17

1 reference

18 August 2017

L G Rider

18

1 reference

18 August 2017

11 December 2008

1 reference

18 August 2017

1 reference

18 August 2017

48

1 reference

18 August 2017

2

1 reference

18 August 2017

134-139

1 reference

Long-term outcome in polymyositis and dermatomyositis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Adult inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Physical activity and disablement in the idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Defining Clinical Improvement in Adult and Juvenile Myositis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Immunoglobulin therapy in inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis-dermatomyositis--a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis (second of two parts)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Assessment of muscle strength in children with meningomyelocele: accuracy and stability of measurements over time.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polyarticular disability: a functional assessment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Prognosis and mortality of polymyositis and dermatomyositis patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Survival, mortality and causes of death in inflammatory myopathies

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Relationship of knee extension force to independence in sit-to-stand performance in patients receiving acute rehabilitation

4 December 2018

1 reference

12 December 2020

Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies11The opinions expressed in this article reflect the views of the authors and are not necessarily those of the National Institu

1 reference

12 December 2020

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

12 December 2020

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

12 December 2020

Analysis of the outcome of idiopathic inflammatory myopathies with particular emphasis on muscle capillary damage

1 reference

12 December 2020

The relationship of strength to function in the older adult

1 reference

12 December 2020

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

12 December 2020

A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

12 December 2020

National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis

1 reference

12 December 2020

10.1093/RHEUMATOLOGY/KEN441

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19074186

1 reference